GIM
BIIB icon

Gyrus Investment Management’s Biogen BIIB Stock Holding History

Gyrus Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,420
Closed -$2.29M – 11
2015
Q1 		$2.29M Buy
5,420
+4,675
+628% +$1.84M 0.38% 86
2014
Q4 		$253K Buy
+745
New +$241K 0.04% 102

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Gyrus Investment Management's BIIB Position: Q2 2015 in Review

Gyrus Investment Management sold out of Biogen (BIIB) in Q2 2015, closing a stake of 5,420 shares — an estimated $2.29M sold.

Gyrus Investment Management first reported a position in BIIB in Q4 2014 and held it in 2 quarters. The position peaked at $2.29M in Q1 2015. 973 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

  • Gyrus Investment Management reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
  • Gyrus Investment Management sold 5,420 Biogen shares in Q2 2015, an estimated $2.29M.
  • Gyrus Investment Management first reported a position in Biogen in Q4 2014 and held it in 2 quarters.
  • Gyrus Investment Management's Biogen position peaked at $2.29M in Q1 2015.
  • 973 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on Gyrus Investment Management's 13F filing for Q2 2015.